New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea
Oncology January 30,2024
First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea
Oncology January 30,2024
Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

by University of North Carolina at Chapel Hill School of Medicine(A) Diagram of model structure. (B) Flowchart of study design. Credit:Annals of Surgical Oncology(2023). DOI: 10.1245/
Oncology January 30,2024
Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

by University of North Carolina at Chapel Hill School of Medicine(A) Diagram of model structure. (B) Flowchart of study design. Credit:Annals of Surgical Oncology(2023). DOI: 10.1245/
Oncology January 30,2024
Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Oncology January 30,2024
Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Oncology January 30,2024
Research predicts cancer patients' response to chemotherapy agent cisplatin

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e
Oncology January 30,2024
Research predicts cancer patients' response to chemotherapy agent cisplatin

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e
Oncology January 30,2024
Drugmaker GSK says EU to review womb cancer treatment

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in
Oncology January 30,2024
Drugmaker GSK says EU to review womb cancer treatment

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in
Oncology January 30,2024
Researchers find new, safer treatment for serious side effect of bone marrow transplant

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear
Oncology January 30,2024
Researchers find new, safer treatment for serious side effect of bone marrow transplant

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear
Oncology January 30,2024
Drug combo ups progression-free survival for metastatic prostate cancer

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Oncology January 30,2024
Drug combo ups progression-free survival for metastatic prostate cancer

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Oncology January 30,2024
Cancer cell repopulation after therapy: Study explores the mechanism

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca
Oncology January 30,2024
Cancer cell repopulation after therapy: Study explores the mechanism

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca
Oncology January 30,2024
Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean
Oncology January 30,2024
Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean
Oncology January 30,2024
Researchers develop liquid biopsy test for pediatric solid tumors

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a
Oncology January 30,2024
Researchers develop liquid biopsy test for pediatric solid tumors

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com